{"id":"W2095886291","doi":"10.1124/mol.111.071787","title":"In Vivo and In Vitro Characterization of a First-in-Class Novel Azole Analog That Targets Pregnane X Receptor Activation","year":2011,"lang":"en","type":"article","venue":"Molecular Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Theratechnologies (Canada)","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Damon Runyon Cancer Research Foundation","keywords":"Pregnane X receptor; Constitutive androstane receptor; Pharmacology; In vivo; Chemistry; Nuclear receptor; Receptor; Biology; Biochemistry; Transcription factor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006506425,0.0003097859,0.0005212217,0.0006694525,0.00004907588,0.000006196154,0.000270637,0.0003889493,0.001499964],"category_scores_gemma":[0.0000326894,0.0003497895,0.00006766435,0.0005510072,0.0001852894,0.0002249236,0.0001461922,0.0006484665,0.00001052128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009519476,"about_ca_system_score_gemma":0.00006993173,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000100159,"about_ca_topic_score_gemma":0.00003652234,"domain_scores_codex":[0.9976507,0.0004923748,0.0006107974,0.0005069068,0.000150151,0.0005891085],"domain_scores_gemma":[0.9992423,0.0001198977,0.00028148,0.0001469869,0.00006686761,0.0001424693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001569752,0.001135927,0.009945488,0.00009101,0.00007404378,0.0000764958,0.001537065,0.000180385,0.9839212,0.0001264946,0.0001034877,0.001238635],"study_design_scores_gemma":[0.005723735,0.00005844279,0.01282933,0.00002369148,0.00006724492,0.000008112195,0.00003524382,0.004928644,0.9618957,0.0001486619,0.01398726,0.000293946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955706,0.0005203972,0.0003602222,0.0006401869,0.0009863683,0.0008548886,0.00009756535,0.0000214728,0.0009482793],"genre_scores_gemma":[0.9960152,0.001056705,0.0003293734,0.002157539,0.00007010934,0.0002078326,0.00004855529,0.0000385411,0.00007617794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02202552,"threshold_uncertainty_score":0.9998954,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06212254743634515,"score_gpt":0.3450595616488686,"score_spread":0.2829370142125234,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}